Search results for "infarct"

showing 10 items of 1223 documents

Differential Prognostic Effect of Revascularization According to a Simple Comorbidity Index in High-Risk Non-ST-Segment Elevation Acute Coronary Synd…

2011

Background: Data on the effect of revascularization on outcome in patients with high-risk non–ST-segment elevation acute coronary syndrome (NSTEACS) and significant comorbidities are scarce. Recently, a simple comorbidity index (SCI) including 5 comorbidities (renal failure, dementia, peripheral artery disease, heart failure, and prior myocardial infarction [MI]) has shown to be a useful tool for risk stratification. Nevertheless, therapeutic implications have not been derived. Hypothesis: We sought to evaluate the prognostic effect attributable to revascularization in NSTEACS according the SCI score. Methods: We included 1017 consecutive patients with NSTEACS. The effect of revascularizati…

Malemedicine.medical_specialtyAcute coronary syndromeTime Factorsmedicine.medical_treatmentDecision MakingStatistics as TopicClinical InvestigationsComorbidityKaplan-Meier EstimateRevascularizationRisk AssessmentInterquartile rangeInternal medicineConfidence IntervalsmedicineHealth Status IndicatorsHumansST segmentProspective StudiesMyocardial infarctionAcute Coronary SyndromePropensity ScoreAgedProportional Hazards Modelsbusiness.industryProportional hazards modelHazard ratioGeneral MedicineMiddle AgedPrognosismedicine.diseaseTroponinConfidence intervalSurgerySpainCardiologyFemaleCardiology and Cardiovascular MedicinebusinessClinical Cardiology
researchProduct

High levels of N-terminal pro B-type natriuretic peptide are associated with ST resolution failure after reperfusion for acute myocardial infarction

2007

Background: B-type natriuretic peptide and the N-terminal fragment of its prohormone, N-terminal pro-brain natriuretic peptide (Nt-proBNP), provide valuable prognostic information on short- and long-term mortality in patients with acute coronary syndrome Aim: To investigate the association between plasma NT-proBNP levels and ST-segment resolution (STR) after reperfusion in patients with ST-segment elevation myocardial infarction (STEMI). Methods: Consecutive patients from the French regional RICO survey with STEMI who were treated by primary PCI or lysis <12 h were included. Blood sample was taken on admission to measure plasma NT-proBNP. Maximal ST segment elevation was measured on the sin…

Malemedicine.medical_specialtyAcute coronary syndromemedicine.drug_classMyocardial InfarctionMyocardial ReperfusionElectrocardiographyReperfusion therapyInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansBlood testST segmentcardiovascular diseasesMyocardial infarctionAgedmedicine.diagnostic_testbusiness.industrysocial sciencesGeneral MedicineMiddle AgedBrain natriuretic peptidemedicine.diseasePeptide Fragmentshumanitieseye diseasesEarly DiagnosisCardiologyFemalebusinessElectrocardiographyBiomarkersgeographic locationsQJM
researchProduct

Outcome of extracorporeal membrane oxygenation support for high-risk percutaneous coronary intervention in non-ST-segment elevation acute coronary sy…

2020

Malemedicine.medical_specialtyAcute coronary syndromemedicine.medical_treatmentHemorrhageComorbidityRisk AssessmentSeverity of Illness IndexRussiaVentricular Dysfunction LeftText miningExtracorporeal Membrane OxygenationPercutaneous Coronary InterventionPostoperative Complicationscoronary intervention non-ST-segment elevation acute coronary syndromeInternal medicinemedicineExtracorporeal membrane oxygenationST segmentHumansNon-ST Elevated Myocardial InfarctionAgedbusiness.industryPatient SelectionPercutaneous coronary interventionGeneral Medicinemedicine.diseaseSurvival AnalysisOutcome and Process Assessment Health CareCoronary OcclusionCardiologyextracorporeal membrane oxygenation high-risk percutaneouFemaleRisk AdjustmentCardiology and Cardiovascular MedicinebusinessJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

An Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes. From Large Trials to the Real World

2004

Introduction and objectives We report the impact on prognosis of an invasive strategy used at our center for non-ST-segment elevation acute coronary syndrome. Patients and method We analyzed 504 consecutive patients with typical chest pain, electrocardiographic changes or increased troponin I serum values, who were divided into 2 cohorts: a ) conservative group, 272 patients admitted between October 2001 and September 2002 and managed with a conservative strategy, and b ) invasive group, 232 patients admitted between October 2002 and September 2003 for whom an invasive strategy was recommended. We recorded major events (death or reinfarction) and minor events (readmission or need for post-d…

Malemedicine.medical_specialtyAcute coronary syndromemedicine.medical_treatmentMyocardial InfarctionChest painRevascularizationAngioplastyInternal medicinemedicineHumansST segmentAngina UnstableAgedUnstable anginabusiness.industryIncidence (epidemiology)AngioplastyHazard ratioSyndromeGeneral MedicinePrognosismedicine.diseaseSurgeryAcute DiseaseCardiologyFemalemedicine.symptombusinessRevista Española de Cardiología (English Edition)
researchProduct

Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiog…

2017

We assessed incidence, predictors, and impact on 6-month mortality of contrast-induced acute kidney injury (CI-AKI) after coronary angiography with or without percutaneous coronary intervention in patients with acute coronary syndrome (ACS), according to 3 different CI-AKI definitions. Serum creatinine (sCr) was assessed at baseline and 48 to 72 hours after procedure to classify patients into 3 CI-AKI groups: Group 1: increase in sCR ≥25% over baseline but absolute increase 25% in the remaining 844 (84.2%). CI-AKI was significantly associated with 6-month all-cause mortality using the definitions for Group 2 (hazard ratio 3.1, 95% confidence interval [CI] 1.5 to 6.6, p = 0.002) and Group 3 …

Malemedicine.medical_specialtyAcute coronary syndromemedicine.medical_treatmentPopulationRenal functionContrast Media030204 cardiovascular system & hematologyCoronary Angiography03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRisk FactorsInternal medicineCause of DeathmedicineRisk of mortalityHumans030212 general & internal medicineAcute Coronary SyndromeMortalityeducationAgededucation.field_of_studybusiness.industryIncidenceHazard ratioAcute kidney injuryPercutaneous coronary interventionAcute Kidney InjuryMiddle Agedmedicine.diseaseConfidence intervalCreatinineCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateThe American journal of cardiology
researchProduct

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study

2008

In primary prevention, the adipocytokine adiponectin seems to be protective against diabetes mellitus and cardiovascular disease. Data in patients with manifest coronary artery disease (CAD) are scant stimulating the investigation of the association of adiponectin concentrations and cardiovascular outcome in a prospective CAD cohort.In 1890 consecutive patients with documented CAD [1130 with stable angina (SAP) and 760 with acute coronary syndrome (ACS)] baseline concentrations of adiponectin were measured by enzyme-linked immuno assay. During a median follow-up of 2.5 years cardiovascular events were registered (cardiovascular deaths 70; non-fatal myocardial infarction 46). Baseline adipon…

Malemedicine.medical_specialtyAdiponectinbusiness.industryCoronary Artery DiseaseMiddle AgedBrain natriuretic peptidemedicine.diseaseAngina PectorisCoronary artery diseaseDiabetes mellitusInternal medicinemedicineCardiologyHumansPopulation studyFemaleAdiponectinMyocardial infarctionAcute Coronary SyndromeRisk factorEpidemiologic MethodsCardiology and Cardiovascular MedicinebusinessComplicationEuropean Heart Journal
researchProduct

Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic f…

2004

Background Aldosterone (ALDO) exerts profibrotic effects, acting via the mineralocorticoid receptors in cardiovascular tissues. Aldosterone antagonism in combination with angiotensin-converting enzyme inhibition may better protect against the untoward effects of ALDO than angiotensin-converting enzyme inhibition alone. Methods In a double-blind randomized study, the tolerability and efficacy of canrenoate (25 mg/d) plus captopril versus captopril alone were evaluated in 510 patients with an acute anterior myocardial infarction (MI), a serum creatinine concentration 5.5 mEq/L and creatinine levels to >2.0 mg/L after 10 days of treatment were observed. At 180 days, the mitral E-wave–A-wave ra…

Malemedicine.medical_specialtyAngiotensin-Converting Enzyme Inhibitors Mineralocorticoid Receptor Antagonists/administration & dosage Myocardial Contraction/drug effects Myocardial Infarction/drug therapy Myocardial Infarction/physiopathologymedicine.drug_classMyocardial InfarctionDiastoleAngiotensin-Converting Enzyme InhibitorsPlacebochemistry.chemical_compoundDouble-Blind MethodInternal medicinemedicineHumansMineralocorticoid Receptor AntagonistsCreatinineAldosteronebiologybusiness.industryCaptoprilAngiotensin-converting enzymeMiddle AgedMyocardial ContractionchemistryTolerabilityMineralocorticoidCardiologybiology.proteinDrug Therapy CombinationFemaleCanrenoic AcidCardiology and Cardiovascular MedicinebusinessFollow-Up Studiesmedicine.drugAmerican Heart Journal
researchProduct

Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease

2005

Abstract Background Lipoproteins and their subfractions are associated with the incidence of atherosclerotic diseases. In patients with coronary artery disease (CAD), low serum concentrations of high density lipoprotein (HDL) and high low-density lipoproteins (LDL) are correlated to myocardial infarction and cardiovascular death. There is growing evidence indicating that those lipoprotein factors are related to the inflammatory process in atherogenesis. Methods We investigated in a median follow up of 3.9 years the association of HDL, apolipoprotein A-I (apoA-I), LDL, apolipoprotein B (apoB), and triglycerides with the incidence of a combined endpoint (myocardial infarction and cardiovascul…

Malemedicine.medical_specialtyApolipoprotein BLipoproteinsInflammationCoronary Artery DiseaseRisk AssessmentCoronary artery diseasechemistry.chemical_compoundHigh-density lipoproteinRisk FactorsInternal medicinemedicineHumansProspective StudiesMyocardial infarctionProspective cohort studyAgedInflammationUnivariate analysisApolipoprotein A-Ibiologybusiness.industrynutritional and metabolic diseasesMiddle AgedPrognosismedicine.diseasechemistrybiology.proteinCardiologyFemalelipids (amino acids peptides and proteins)medicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersLipoproteinInternational Journal of Cardiology
researchProduct

Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy.

2014

INTRODUCTION: The aim of this study was to determine prognostic factors for the risk of new vascular events during the first 6 months after acute myocardial infarction (AMI) or atherothrombotic stroke (AS). We were interested in the prognostic role of endothelial progenitor cells (EPC) and circulating endothelial cells (CEC). METHODS: Between February 2009 and July 2012, 100 AMI and 50 AS patients were consecutively studied in three Spanish centres. Patients with previously documented coronary artery disease or ischemic strokes were excluded. Samples were collected within 24h of onset of symptoms. EPC and CEC were studied using flow cytometry and categorized by quartiles. Patients were foll…

Malemedicine.medical_specialtyAtherothrombotic strokeScienceHypercholesterolemiaMyocardial InfarctionRisk FactorsInternal medicineDiabetes mellitusmedicineHumansCorMyocardial infarctioncardiovascular diseasesProgenitor cellStrokeAgedEndothelial Progenitor CellsSistema cardiovascularMultidisciplinarybusiness.industryQFollow up studiesRMiddle AgedPrognosismedicine.diseaseStrokeStenosisDiabetes Mellitus Type 2Cardiovascular DiseasesInfart de miocardi -- Factors de riscAcute DiseaseHypertensionCardiologycardiovascular systemMyocardial infarction complicationsMedicineFemalebusinessFollow-Up StudiesResearch ArticlePLoS ONE
researchProduct

Blood Transfusion in Elderly Patients with Acute Myocardial Infarction: Data from the RICO Survey.

2017

Red blood cell transfusion benefit during acute myocardial infarction remains unclear in the elderly. We aimed to assess the transfusion impact on 1-year mortality in acute myocardial infarction patients aged ≥65 years, according to their age and hemoglobin nadir.We included 3316 consecutive patients with acute myocardial infarction aged ≥65 years from the "obseRvatoire des Infarctus de Côte d'Or" (RICO) survey. They were categorized according to their hemoglobin nadir (≤8,8 to ≤10, and10 g/dL) and age (80 or ≥80 years).A total of 1906 patients (57%) were 65-79 years old, and 1410 (43%) were aged ≥80 years, of whom 103 (5%) and 145 (10%) patients received red blood cell transfusion, respect…

Malemedicine.medical_specialtyBlood transfusionAnemiamedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesHemoglobins0302 clinical medicineOlder patientsInternal medicinemedicineHumansIn patientBlood Transfusion030212 general & internal medicineMyocardial infarctionProspective StudiesAgedAged 80 and overbusiness.industryAnemiaGeneral Medicinemedicine.diseaseConfidence intervalSurgeryTreatment OutcomeFemaleHemoglobinFrancebusinessNadir (topography)The American journal of medicine
researchProduct